Whittier Trust CO Sangamo Therapeutics, Inc Transaction History

Whittier Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$4.27 - $6.39 $2,848 - $4,262	-667 Reduced 63.65%	381 $2,000
Q4 2021 Jan 19, 2022	BUY	$7.29 - $10.97 $4,862 - $7,316	667 Added 175.07%	1,048 $8,000
Q2 2020 Jul 10, 2020	SELL	$6.21 - $11.83 $310 - $591	-50 Reduced 11.6%	381 $3,000
Q4 2019 Jan 31, 2020	SELL	$8.03 - $11.7 $6,022 - $8,775	-750 Reduced 63.51%	431 $4,000
Q3 2019 Oct 18, 2019	BUY	$9.05 - $12.22 $7,240 - $9,776	800 Added 209.97%	1,181 $11,000
Q2 2018 Jul 27, 2018	BUY	$13.9 - $19.8 $5,295 - $7,543	381 New	381 $5,000

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $178M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.